tiprankstipranks
Agios Pharma (GB:0HB0)
LSE:0HB0
Holding GB:0HB0?
Track your performance easily

Agios Pharma (0HB0) Technical Analysis

1 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Agios Pharma’s (0HB0) Moving Averages Convergence Divergence (MACD) indicator is -4.16, suggesting Agios Pharma is a Buy.
Agios Pharma’s (0HB0) 20-Day exponential moving average is 46.70, while Agios Pharma’s (0HB0) share price is $35.638, making it a Sell.
Agios Pharma’s (0HB0) 50-Day exponential moving average is 48.72, while Agios Pharma’s (0HB0) share price is $35.638, making it a Sell.

Agios Pharma (0HB0) Pivot Points

Dec 22, 2024, 08:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.58
34.47
35.68
37.57
38.79
40.67
41.89
Fibonacci
34.47
35.66
36.39
37.57
38.76
39.49
40.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (0HB0) Moving Averages

Dec 22, 2024, 08:17 AM
Period
Simple
Exponential
MA5
39.90Sell
39.01Sell
MA10
41.47Sell
42.49Sell
MA20
50.43Sell
46.70Sell
MA50
49.84Sell
48.72Sell
MA100
47.19Sell
47.10Sell
MA200
42.46Sell
41.69Sell
Agios Pharma’s (0HB0) 10-Day exponential moving average is 42.49, while Agios Pharma’s (0HB0) share price is $35.638, making it a Sell.
Agios Pharma’s (0HB0) 100-Day exponential moving average is 47.10, while Agios Pharma’s (0HB0) share price is $35.638, making it a Sell.
Agios Pharma’s (0HB0) stock price is $35.638 and Agios Pharma’s (0HB0) 50-day simple moving average is 49.84, creating a Sell signal.
Agios Pharma’s (0HB0) stock price is $35.638 and Agios Pharma’s (0HB0) 100-day simple moving average is 47.19, creating a Sell signal.
Agios Pharma’s (0HB0) stock price is $35.638 and Agios Pharma’s (0HB0) 200-day simple moving average is 42.46, creating a Sell signal.

Agios Pharma (0HB0) Technical Indicators

Dec 22, 2024, 08:17 AM
Name
Value
Implied Action
RSI (14)
29.41
Buy
STOCH (9,6)
7.79
Buy
STOCHRSI (14)
7.16
Buy
MACD (12,26)
-4.16
Buy
ADX (14)
31.29
Neutral
Williams %R
-98.18
Buy
CCI (14)
-116.72
Buy
ATR (14)
3.22
-
Ultimate Oscillator
34.10
Neutral
ROC
-40.18
Sell
Agios Pharma’s (0HB0) Relative Strength Index (RSI) is 29.41, creating a Buy signal.
Agios Pharma’s (0HB0) Trend Strength Indicator (ADX) is 31.29, creating a Neutral signal.
Agios Pharma’s (0HB0) Commodity Channel Index (CCI) is -116.72, creating a Buy signal.
Agios Pharma’s (0HB0) Price Rate of Change (ROC) is -40.18, creating a Sell signal.

FAQ

Is 0HB0 a Buy, Hold, or Sell?
Based on 0HB0’s technical indicators, 0HB0 is a Sell.
    What is 0HB0’s RSI (14)?
    0HB0’s RSI (14) is 29.41, which suggests 0HB0 is a Buy.
      What is 0HB0’s MACD?
      0HB0’s MACD is -4.16, which suggests 0HB0 is a Buy.
        What is 0HB0’s 5-day moving average?
        0HB0’s 5-day moving average is 39.90, which suggests 0HB0 is a Sell.
          What is 0HB0’s 20-day moving average?
          0HB0 20-day moving average is 50.43, which suggests 0HB0 is a Sell.
            What is 0HB0’s 50-day moving average?
            0HB0’s 50-day moving average is 49.84, which suggests 0HB0 is a Sell.
              What is 0HB0’s 200-day moving average?
              0HB0’s 200-day moving average is 42.46, which suggests 0HB0 is a Sell.
                What is 0HB0’s Williams % R (14)?
                0HB0’s Williams % R (14) is -98.18, which suggests 0HB0 is a Buy.
                  What is 0HB0’s CCI (14)?
                  0HB0’s CCI (14) is -116.72, which suggests 0HB0 is a Buy.
                    What is the share price of Agios Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis